跳至主要内容
临床试验/NCT04602949
NCT04602949已完成不适用

Detection of the 2019 Novel Coronavirus (SARS-CoV-2) Using Breath Analysis - Validation Study

Scentech Medical Technologies Ltd1 个研究点 分布在 1 个国家目标入组 2,558 人开始时间: 2020年11月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,558
试验地点
1
主要终点
Presence of Volatile Organic Compounds indicating carriers of COVID-19.

研究概览

简要总结

DETECTION OF THE 2019 NOVEL CORONAVIRUS (SARS-CoV-2) USING BREATH ANALYSIS- VALIDATION STUDY

详细描述

A diagnostic prospective single-site study, with no anticipated risks or constraints.

Primary objective- To validate the value of a set of breath VOC biomarkers that enable us to distinguish between Coronavirus (SARS-CoV-2) carriers and SARS-CoV-2-negative in comparison to the gold-standard testing methodology.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
6 Years 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 6 to 75 years at the time of consent
  • Capable of understanding written and/or spoken language
  • Able to provide informed consent
  • Was not treated with Anti-viral drugs

排除标准

  • Age under 6 years old
  • Under guardianship or deprived of liberty
  • Pregnant or lactating woman

结局指标

主要结局

Presence of Volatile Organic Compounds indicating carriers of COVID-19.

时间窗: Through the study completion, up to 3 months.

Comparison of Volatile Organic Compounds found among COVID-19 carriers and Healthy controls.

次要结局

  • sensitivity level of biomarkers' algorithm.(Through the study completion, up to 3 months.)
  • Association of exhaled biomarkers with participants' characteristics (age, gender, symptoms-severity, etc.).(Through the study completion, up to 3 months.)

研究者

发起方
Scentech Medical Technologies Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验